imp288
mAbexperimentalImaging agent
Clinical trial activity
5 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2009 (NCT00860860)
Timeline
Indications
Mechanism of action
- Carcinoembryonic antigen-related cell adhesion molecule 5Immunity, passive
CEACAM5 immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 111-indium
Oral
No
Parenteral
No
Topical
No
Also known as
- dota-d-tyr-d-lys(hsg)-d-glu-d-lys(hsg)-nh2
- dota-tyr-lys(hsg)-glu-lys(hsg)-nh2
- dota-tyrosyl-lysyl(histaminyl-succinyl-glycyl)-glutamyl-lysyl(histaminyl-succinyl-glycyl)amide
- imp288
- imp 288
- imp-288
- imp-288
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02587247 | Phase 2 | Mar 1, 2016 | University of Nantes |
| NCT01730612 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2012 | Immunomedics, Institut National de la Santé Et de la Recherche Médicale, France, University of Nantes |
| NCT01221675 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2011 | Institut de Cancerologie de l'Ouest Paul Papin |
| NCT01273402 | Phase 1 | Feb 1, 2011 | Garden State Cancer Center, Immunomedics, National Cancer Institute (NCI) |
| NCT00860860 | Phase 1 | Jul 1, 2009 | Radboud University, Richmond University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Immunomedics | For profit | 2 | 1 | 2 | 2011 |
| University of Nantes | Academic/Hospital | 2 | 2 | 1 | 2012 |
| Garden State Cancer Center | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Institut de Cancerologie de l'Ouest Paul Papin | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Institut National de la Santé Et de la Recherche Médicale, France | Academic/Hospital | 1 | 0 | 1 | 2012 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2011 |
| Radboud University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Richmond University | Academic/Hospital | 1 | 0 | 1 | 2009 |
8 organizations
Page 1 / 1